DK2288364T3 - Fremgangsmåder til behandling eller forebyggelse af diabetes mellitus og andre metaboliske ubalancer - Google Patents

Fremgangsmåder til behandling eller forebyggelse af diabetes mellitus og andre metaboliske ubalancer

Info

Publication number
DK2288364T3
DK2288364T3 DK09755464.6T DK09755464T DK2288364T3 DK 2288364 T3 DK2288364 T3 DK 2288364T3 DK 09755464 T DK09755464 T DK 09755464T DK 2288364 T3 DK2288364 T3 DK 2288364T3
Authority
DK
Denmark
Prior art keywords
treating
methods
diabetes mellitus
preventing diabetes
metabolic imbalances
Prior art date
Application number
DK09755464.6T
Other languages
English (en)
Inventor
Kenneth C Hayes
Kalyana Sundram
Ravigadevi Sambanthamurthi
Yew Ai Tan
Original Assignee
Univ Brandeis
Malaysian Palm Oil Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brandeis, Malaysian Palm Oil Board filed Critical Univ Brandeis
Application granted granted Critical
Publication of DK2288364T3 publication Critical patent/DK2288364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK09755464.6T 2008-04-02 2009-04-02 Fremgangsmåder til behandling eller forebyggelse af diabetes mellitus og andre metaboliske ubalancer DK2288364T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/080,361 US8071143B2 (en) 2008-04-02 2008-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
PCT/US2009/039296 WO2009146102A1 (en) 2008-04-02 2009-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances

Publications (1)

Publication Number Publication Date
DK2288364T3 true DK2288364T3 (da) 2014-05-26

Family

ID=41133491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09755464.6T DK2288364T3 (da) 2008-04-02 2009-04-02 Fremgangsmåder til behandling eller forebyggelse af diabetes mellitus og andre metaboliske ubalancer

Country Status (11)

Country Link
US (2) US8071143B2 (da)
EP (1) EP2288364B1 (da)
JP (3) JP2011518131A (da)
CN (1) CN102088988B (da)
AU (1) AU2009251568B2 (da)
BR (1) BRPI0911083A8 (da)
DK (1) DK2288364T3 (da)
ES (1) ES2474726T3 (da)
MY (1) MY153112A (da)
PL (1) PL2288364T3 (da)
WO (1) WO2009146102A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY161839A (en) 2009-05-18 2017-05-15 Malaysian Palm Oil Board A composition for use in the prevention and treatment of cardiovascular diseases
MY173655A (en) * 2009-06-09 2020-02-14 Malaysian Palm Oil Board Composition and method for improving vascular health
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN101982115A (zh) * 2010-10-14 2011-03-02 张丽娜 一种防治糖尿病慢性糖中毒的组合物
US10178869B2 (en) 2011-02-11 2019-01-15 Roberto Crea Treatment of Elaeis fruit products with antioxidants
US20150030710A1 (en) * 2011-05-18 2015-01-29 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liquor for inhibition of vision loss due to angiogenesis and method of preparation there
WO2012158018A2 (en) * 2011-05-18 2012-11-22 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liguor for inhibition of vision loss due to angiogenesis and method of preparation thereof
BR112014005104A2 (pt) 2011-09-02 2017-07-04 Salk Inst For Biological Studi inibidores camkii, ip3r, calcineurin, p38 e mk2/3 para tratar atar distúrbios metabólicos de obesidade
MY179036A (en) 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
WO2014124140A1 (en) * 2013-02-06 2014-08-14 Brandeis University Treatment of dna damage and mitochondrial dysfunction using palm fruit juice
KR102403048B1 (ko) * 2016-06-13 2022-05-26 신유알엑스 인터내셔널 (타이완) 코포레이션 벤조산나트륨의 공-결정 및 그의 용도
TWI736635B (zh) 2016-06-13 2021-08-21 心悅生醫股份有限公司 苯甲酸鋰之共晶及其用途
CN108355034A (zh) * 2018-05-02 2018-08-03 黑龙江中医药大学 一种用于治疗多囊卵巢综合征着床障碍的中药制剂及其制备方法
CN109172712A (zh) * 2018-10-09 2019-01-11 昆明理工大学 棕榈果提取物的用途
CN109464561A (zh) * 2018-10-09 2019-03-15 昆明理工大学 棕榈果提取物的用途
EP4404923A1 (en) * 2021-09-23 2024-07-31 Alkalay, Rachel Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126474A (en) * 1996-04-12 2001-03-19 Beth Israel Hospital Diabetic supplement bar
MY134878A (en) * 1998-09-24 2007-12-31 Palm Oil Res And Dev Board Treatment of liquors derived from oil-bearing fruit.
JP4220247B2 (ja) 2001-03-29 2009-02-04 ビーエーエスエフ ソシエタス・ヨーロピア 共役不飽和グリセリド混合物及びその製造方法
JP4324335B2 (ja) * 2001-09-07 2009-09-02 花王株式会社 カテキン含有飲料
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びｇｌｕｔ４トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
DK1868454T3 (da) * 2005-04-06 2013-04-02 Nestec Sa Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning

Also Published As

Publication number Publication date
AU2009251568A1 (en) 2009-12-03
CN102088988B (zh) 2013-05-29
JP2014193930A (ja) 2014-10-09
JP2011518131A (ja) 2011-06-23
US20090252817A1 (en) 2009-10-08
US20120114775A1 (en) 2012-05-10
BRPI0911083A8 (pt) 2018-08-28
US8071143B2 (en) 2011-12-06
JP6421961B2 (ja) 2018-11-14
PL2288364T3 (pl) 2014-08-29
EP2288364A1 (en) 2011-03-02
MY153112A (en) 2014-12-31
EP2288364B1 (en) 2014-03-26
US9326957B2 (en) 2016-05-03
WO2009146102A1 (en) 2009-12-03
CN102088988A (zh) 2011-06-08
JP2017186354A (ja) 2017-10-12
BRPI0911083A2 (pt) 2015-10-06
ES2474726T3 (es) 2014-07-09
AU2009251568B2 (en) 2014-08-14
EP2288364A4 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
DK2260657T3 (da) Fremgangsmåde og system til at lette udøvelsen af automatiske naborelationsfunktioner
DK2252312T3 (da) Fremgangsmåder til forebyggelse eller behandling af insulinresistens
BRPI0911083A8 (pt) métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos
DK2555807T3 (da) Skabelon-øceller og små øcelleklynger til behandling af diabetes
DK2300808T3 (da) Systemer og fremgangsmåder til billeddannelse ved anvendelse af absorption
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK2326357T3 (da) Sammensætning og fremgangsmåde til behandling af vævsdefekter
DK2252342T3 (da) Indretninger og fremgangsmåder til behandling af skadet væv
BRPI0919575A2 (pt) método, e, composição
DK2188336T3 (da) Sammensætning omfattende et eller flere hydrofobt modificerede polyacrylamider og fremgangsmåde til anvendelse af sammensætningen
NO20082795L (no) Blandeapparat og framgangsmate ved bruk av samme
BRPI0822914A2 (pt) Composição, filme e métodos relacionados
BRPI0823277A2 (pt) Composição, e , método
DK2170360T3 (da) Urtesammensætning til behandling af diabetes og/eller forstyrrelser forbundet dermed
DK2753187T4 (da) Fremgangsmåde til forebyggelse og/eller behandling af insulinresistens
BRPI0918170A2 (pt) método, e, composição endurecível
BRPI0920284A2 (pt) composição e método
DK2264259T3 (da) Panel, anvendelse af et panel, fremgangsmåde til fremstilling af et panel og et prepreg
DK2568881T3 (da) Indretning til anvendelse ved diagnosticering og/eller behandling af neurologisk lidelse
BRPI0809573A2 (pt) composição, e, método
DK2518655T3 (da) Anordning og fremgangsmåde til forebyggelse af hypoglykæmi
DK2229800T3 (da) Fremgangsmåde og apparat til frigørelse af ressourcer
DK2102398T3 (da) Fremgangsmåde til fremstilling af en ankelsok og ankelsok opnået derved
DK2294228T3 (da) Fremgangsmåde til forbehandling af planteudgangsmateriale til fremstillingen, fra sukkerholdige og lignocellulose-holdige ressourcer, af bioethanol og/eller af sukker
BRPI0906094A2 (pt) composto e método de tratamento de diabetes do tipo ii